A recent report, proposing the function of cytoplasmic NIS as an element of a pathway involved in tumor cell invasive capacity[76], suggests a role of cytoplasmic NIS in tumor aggressiveness, strengthening the hypothesis of using NIS expression as biomarker for defining individuals with biologically active prostate cancer. This evidence concerns the gene SLC5A5 and prostate cancer.